OUR PRODUCTS
OUR PRODUCTS
Crystal egg biology is committed to the research and development of membrane protein innovative drugs for major diseases such as chronic kidney disease and malignant tumor, and is determined to become a highly innovative and influential enterprise in the world.
More
OUR SERVICE
OUR SERVICE

Membrane proteins, including G protein coupled receptors, ion channels and transporters, play a key role in almost all physiological processes, including signal transduction, ion and small molecule transport and biological energy conversion. Abnormal function of membrane proteins can lead to cardiovascular disease, cancer, Alzheimer's disease, pain and other related diseases. At present, more than 50% of clinical drugs are designed with membrane proteins as targets.
Our structural biology experts can provide you with the most advanced structural biology technical services in the field of membrane proteins, including crystal structure, freeze electron microscope and NMR. On the one hand, we provide crystal structure services of membrane proteins that have been reported for the research and development of new drugs based on complex crystal structure or fragment; On the other hand, we also provide the structural analysis of membrane proteins, including the identification of the tertiary structure of antigen epitopes. If you are interested in our services, please feel free to contact us for more information.
One stop services include antigen preparation, antibody R & D, kit development, antibody detection to antibody production, antibody humanization, antibody affinity maturation, nano antibody and bispecific nano antibody production. If you are interested in our services, please feel free to contact us for more information.
Dock, discovery studio, Schrodinger and other software were used for protein structure modeling, molecular dynamics simulation, quantum chemical calculation and other molecular simulation calculations. About 100 compounds with high scores were selected, and then tested at the molecular and cellular levels in vitro. Finally, the affinity of 10 compounds was obtained μ M level.
  • Protein factory
  • Antibody production
  • Structural biology
  • Virtual machine Screening
  • ABOUT US
    ABOUT US
    Shenzhen Jingdan Biomedical Technology Co., Ltd. was established in August 2019, dedicated to the research and development of innovative ion channel drugs for major diseases such as depression, pain, and chronic kidney disease. Its goal is to become a leading global enterprise in the research and development of innovative ion channel drugs. The core team is led by a thousand young people and consists of PhDs from top research institutes and pharmaceutical companies such as Harvard University and Shanghai Institute of Pharmacy. We invite Erwin Neher, a Nobel laureate in physiology or medicine and founder of the field of ion channels, as our chief scientific advisor, making us one of the few biotechnology companies to have Nobel laureates. Our research and development capabilities in highly stable ion channel antigen antibodies, structural analysis, drug development based on structure and artificial intelligence, and pharmacology are at a world leading level. The company won the first prize in the biopharmaceutical industry of the Shenzhen Innovation and Entrepreneurship Competition in 2020, the "Science and Technology Innovation China" Leading Technology Award in 2020, the National Excellent Award of the 9th China Innovation and Entrepreneurship Competition, the Top 10 Science and Technology Innovation and Entrepreneurship Competition in China, and awards such as the "Specialized, Refined, and New" Small and Medium Enterprises in Shenzhen.
    >>
    CORE TECHNOLOGIES
    CORE TECHNOLOGIES
    The crystal egg biological core technology platform has first-class instruments and equipment, equipped with molecular cloning room and a variety of protein expression and purification systems, and master a variety of technologies such as lipid cubic phase crystallization and freeze electron microscope.
    NEWS AND PAPERS
    NEWS AND PAPERS